AAR Corp. (AIR) Financials Nov 18, 2014, 11:57 a.m.
Income
AAR Corp. (AIR) Financials Nov 18, 2014, 11:57 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for AAR Corp.
Fiscal year is June-May. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 1.35B 1.78B 2.06B 2.14B 2.04B
Cost of Goods Sold (COGS) incl. D&A 1.11B 1.47B 1.74B 1.82B 1.69B
COGS excluding D&A 1.07B 1.41B 1.66B 1.74B 1.61B
Depreciation & Amortization Expense 38.93M 59.3M 80.33M 79.7M 80.4M
Depreciation 34.36M 49.68M 67.36M 66M 70M
Amortization of Intangibles 4.57M 9.61M 12.97M 13.7M 10.4M
Gross Income 243.52M 308.42M 322.26M 314.2M 340.2M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 153.3M 173.6M 189.4M 198.4M 197.6M
Research & Development 0 0 0 0 -
Other SG&A 153.3M 173.6M 189.4M 198.4M 197.6M
Other Operating Expense 0 0 0 0 0
Unusual Expense (893,000) 5.26M 4.36M (300,000) 0
EBIT after Unusual Expense 893,000 (5.26M) (4.36M) 300,000 0
Non Operating Income/Expense (1.15M) 5.92M 0 0 0
Non-Operating Interest Income 945,000 349,000 1.24M 1.5M 1.6M
Equity in Affiliates (Pretax) 112,000 3.34M 1.54M 6.8M 3.1M
Interest Expense 26.83M 30.67M 37.77M 42.2M 42M
Gross Interest Expense 26.83M 30.67M 37.77M 42.2M 42M
Interest Capitalized 0 0 0 0 0
Pretax Income 64.19M 108.5M 93.51M 82.2M 105.3M
Income Tax 20.99M 35.36M 25.48M 26.7M 32.1M
Income Tax - Current Domestic 1.8M (5.28M) (10.23M) (14.9M) (300,000)
Income Tax - Current Foreign 23.05M - 2.95M 12.1M 22.8M
Income Tax - Deferred Domestic (3.86M) 40.64M 32.76M 29.5M 9.6M
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 - - -
Equity in Affiliates 0 0 - - -
Other After Tax Income (Expense) 0 (2.28M) (2.55M) (2M) (1.5M)
Consolidated Net Income 43.2M 70.86M 65.48M 53.5M 71.7M
Minority Interest Expense (1.43M) 0 306,000 500,000 300,000
Net Income 44.63M 70.86M 65.18M 53M 71.4M
Extraordinaries & Discontinued Operations 0 (3.31M) 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 (3.31M) 0 0 0
Net Income After Extraordinaries 44.63M 67.55M 65.18M 53M 71.4M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 44.63M 70.86M 65.18M 53M 71.4M
EPS (Basic) 1.17 1.76 1.68 1.38 1.85
Basic Shares Outstanding 38.18M 38.36M 38.81M 38.3M 38.6M
EPS (Diluted) 1.16 1.73 1.65 1.38 1.83
Diluted Shares Outstanding 43.09M 43.59M 43.08M 40.6M 39.1M
EBITDA 129.15M 194.11M 213.19M 195.5M 223M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...
Continue Reading
Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...
Continue Reading
The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...
Continue Reading
Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...
Continue Reading
Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...
Continue Reading
Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...
Continue Reading
Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...
Continue Reading
Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...
Continue Reading
Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Doximity's Market Standing Doximity's short percent of float has recently seen a notable reduction of 13.66%, indicating a shift in investor sentiment. With a current report showing 4.97 million shares sold short, which constitutes 3.73% of all regular shares available, traders are now called to pay attention to the stock dynamics at play. The average...
Continue Reading
HS Veitur hf. Unveils Annual Financial Report In a recent meeting, the board of HS Veitur hf. announced the approval of the annual financial report for the year 2024. This year-end report showcases the company’s achievements and financial health. Review of 2024's Financial Performance The annual report indicates a promising financial year for HS Veitur hf., reflecting...
Continue Reading
Elis SA's Recent Share Buyback Activities Elis SA has made a mark with its recent trading activities associated with its own shares, particularly highlighting a series of transactions carried out during a specified period. Overview of the Buyback Program As part of its strategic financial planning, Elis has engaged in a buyback program that has garnered attention. The...
Continue Reading
From the U.K. to the U.S.: SURI's Bold Move There's nothing quite like making a splash stateside when you're a brand outta the U.K. And that's exactly what SURI, an oral care company, aimed to do in 2026. Typically, breaking into a new market is like wrestling a bear—one wrong move and you're toast. But SURI managed to pull it off without beefing up their headcount,...
Continue Reading
Stellantis Annual General Meeting Outcomes Stellantis N.V. recently held a significant Annual General Meeting where notable resolutions received the green light from shareholders. The meeting, attended in person and streamed online, showcased Stellantis' commitment to engaging with its stakeholders. Dividend Distribution Approved One of the key highlights was the approval...
Continue Reading